OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
410757

Ise Chemicals Corp

Commodity ChemicalsVerified

Ise Chemicals Corp maintains a strong liquidity position, with a current ratio of 3.5, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's cash and equivalents amount to 4.5 billion JPY, and its operating cash flow of 7.5 billion JPY supports its liquidity needs without reliance on external financing. The debt-to-equity ratio is 0.01, reflecting a conservative capital structure with minimal long-term debt exposure. In terms of profitability, Ise Chemicals Corp demonstrates a return on equity (ROE) of 16.22% and a return on assets (ROA) of 12.74%, both of which exceed the typical benchmarks for the Commodity Chemicals industry. The company's operating income of 9.38 billion JPY and net income of 6.498 billion JPY indicate strong operational efficiency and cost control. These metrics suggest the company is effectively converting its assets into profits, which is a positive sign for investors. The company's revenue is primarily concentrated in its core chemical manufacturing operations, with no disclosed geographic diversification in the provided data. This concentration may expose the company to regional economic fluctuations, but the lack of segment-specific data limits a more detailed assessment. The company's total revenue of 39.258 billion JPY is derived from a single business line, indicating a lack of diversification in its product or market offerings. Looking ahead, Ise Chemicals Corp is projected to maintain a stable growth trajectory, with no significant changes in revenue or earnings expected in the near term. The company's capital expenditure of -2.679 billion JPY suggests a reduction in investment in new projects or facilities, which may indicate a focus on maintaining current operations rather than expansion. This conservative approach to capital spending could be a strategic decision to preserve cash and manage debt levels. The risk assessment for Ise Chemicals Corp indicates a low probability of liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and strong cash reserves further support this assessment. However, the company's reliance on a single business line and geographic concentration could pose long-term risks if market conditions change. The absence of dilution potential and the conservative capital structure suggest the company is not currently under pressure to raise additional capital. Recent events and filings for Ise Chemicals Corp do not indicate any significant changes in the company's operations or financial strategy. The company's latest actual EPS of 127.51 JPY and revenue of 39.258 billion JPY align with its historical performance, suggesting a stable and predictable business model. The lack of recent volatility in financial metrics indicates a well-managed and consistent business operation.

30-day price · 4107-625.00 (-12.5%)
Low$4150.00High$6000.00Close$4385.00As of21 May, 00:00 UTC
Profile
CompanyIse Chemicals Corp
Ticker4107.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Ise Chemicals Corp is a Japanese chemical manufacturer specializing in commodity chemicals, primarily generating revenue through the production and sale of chemical products.

Classification. Ise Chemicals Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a high confidence level of 0.92.

Ise Chemicals Corp maintains a strong liquidity position, with a current ratio of 3.5, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's cash and equivalents amount to 4.5 billion JPY, and its operating cash flow of 7.5 billion JPY supports its liquidity needs without reliance on external financing. The debt-to-equity ratio is 0.01, reflecting a conservative capital structure with minimal long-term debt exposure. In terms of profitability, Ise Chemicals Corp demonstrates a return on equity (ROE) of 16.22% and a return on assets (ROA) of 12.74%, both of which exceed the typical benchmarks for the Commodity Chemicals industry. The company's operating income of 9.38 billion JPY and net income of 6.498 billion JPY indicate strong operational efficiency and cost control. These metrics suggest the company is effectively converting its assets into profits, which is a positive sign for investors. The company's revenue is primarily concentrated in its core chemical manufacturing operations, with no disclosed geographic diversification in the provided data. This concentration may expose the company to regional economic fluctuations, but the lack of segment-specific data limits a more detailed assessment. The company's total revenue of 39.258 billion JPY is derived from a single business line, indicating a lack of diversification in its product or market offerings. Looking ahead, Ise Chemicals Corp is projected to maintain a stable growth trajectory, with no significant changes in revenue or earnings expected in the near term. The company's capital expenditure of -2.679 billion JPY suggests a reduction in investment in new projects or facilities, which may indicate a focus on maintaining current operations rather than expansion. This conservative approach to capital spending could be a strategic decision to preserve cash and manage debt levels. The risk assessment for Ise Chemicals Corp indicates a low probability of liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and strong cash reserves further support this assessment. However, the company's reliance on a single business line and geographic concentration could pose long-term risks if market conditions change. The absence of dilution potential and the conservative capital structure suggest the company is not currently under pressure to raise additional capital. Recent events and filings for Ise Chemicals Corp do not indicate any significant changes in the company's operations or financial strategy. The company's latest actual EPS of 127.51 JPY and revenue of 39.258 billion JPY align with its historical performance, suggesting a stable and predictable business model. The lack of recent volatility in financial metrics indicates a well-managed and consistent business operation.
Key takeaways
  • Ise Chemicals Corp has a strong liquidity position with a current ratio of 3.5 and minimal long-term debt.
  • The company's ROE of 16.22% and ROA of 12.74% indicate strong profitability and efficient asset utilization.
  • Revenue is concentrated in a single business line, which may increase exposure to market fluctuations.
  • The company is projected to maintain a stable growth trajectory with no significant changes in revenue or earnings expected.
  • Low liquidity and dilution risks suggest a conservative financial strategy with no immediate capital-raising pressures.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$39.26B
Gross profit$12.40B
Operating income$9.38B
Net income$6.50B
R&D
SG&A
D&A
SBC
Operating cash flow$7.53B
CapEx-$2.68B
Free cash flow$3.88B
Total assets$51.02B
Total liabilities$10.95B
Total equity$40.07B
Cash & equivalents$4.50B
Long-term debt$567.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$40.07B
Net cash$3.94B
Current ratio3.5
Debt/Equity0.0
ROA12.7%
ROE16.2%
Cash conversion1.2%
CapEx/Revenue-6.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4107Activity
Op margin23.9%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin16.6%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin31.6%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-6.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity1.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS127.51 JPY
Last actual revenue39,258,000,000 JPY
Source: analysis-pipeline (hybrid)Generated: 2026-05-24 16:59 UTCJob: 759b61da